Scientech Research LLC’s Aethlon Medical AEMD Stock Holding History

Scientech Research LLC’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,599	Closed	-$19.5K	–	488
2025 Q3	$19.5K	Buy	+2,599	New	+$30K	0.01%	534
2025 Q1	–	Sell	-282	Closed	-$19.4K	–	550
2024 Q4	$19.4K	Buy	+282	New	+$9.57K	0.01%	535

Other funds holding AEMD

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Scientech Research LLC's AEMD Position: Q4 2025 in Review

Scientech Research LLC sold out of Aethlon Medical (AEMD) in Q4 2025, closing a stake of 2,599 shares — an estimated $19.5K sold.

Scientech Research LLC first reported a position in AEMD in Q4 2024 and held it in 2 quarters. The position peaked at $19.5K in Q3 2025. 8 funds tracked by Wall St. Rank hold AEMD as of Q4 2025.

Scientech Research LLC reported no remaining Aethlon Medical position as of Q4 2025 after selling out during the quarter.
Scientech Research LLC sold 2,599 Aethlon Medical shares in Q4 2025, an estimated $19.5K.
Scientech Research LLC first reported a position in Aethlon Medical in Q4 2024 and held it in 2 quarters.
Scientech Research LLC's Aethlon Medical position peaked at $19.5K in Q3 2025.
8 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2025.

Based on Scientech Research LLC's 13F filing for Q4 2025, filed 17 Feb 2026.